Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.15 +0.01 (+0.88%)
As of: Sep 30, 2026 · 3:58 PM EDT

Actinium Pharmaceuticals (ATNM) Revenue (2021 - 2026)

Updated

Actinium Pharmaceuticals' Revenue came in at $35 million for Q2 2026.

Analysis

Actinium Pharmaceuticals (ATNM) Revenue (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Actinium Pharmaceuticals reported Revenue of $35.09 million; for FY2025, it came in at $90,000.

  • Revenue carries a four-year compound annual growth rate of -47.0% (FY2021 to FY2025).
  • Going back by year, Revenue was $81,000 in FY2023 (-92.1%), $1.03 million in FY2022 (-10.0%) and $1.14 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Revenue in data going back to Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Actinium Pharmaceuticals 35.84 Mn 35.84 Mn - 35.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.00 Mn
Sep 30, 2025 90,000.00
Sep 30, 2022 45,000.00
Jun 30, 2022 45,000.00
Mar 31, 2022 940,000.00
Dec 31, 2021 23,000.00
Sep 30, 2021 233,000.00
Jun 30, 2021 266,000.00
Mar 31, 2021 622,000.00
API Access

Actinium Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ATNM&period=max&api_key=YOUR_API_KEY